ethics
06-11-2003, 09:52 PM
Well, not thoroughly fake but the image can sure be altered!
The growth hormone Humatrope (http://www.humatrope.com/index.jsp) makes children grow taller. For years, it's been used to treat children with growth hormone deficiency and Turner syndrome. But now its manufacturer, Eli Lily & Co., has taken an important step towards selling Humatrope to a much larger population. A panel advising the Food and Drug Administration recommended expanding the use of Humatrope to make healthy but short children grow a few extra inches. (http://online.wsj.com/article_email/0,,SB10552760005584800,00.html)
If the FDA accepts the panel's recommendation, Eli Lily will be allowed to market the drug to pediatric endocrinologists to "treat" a condition that is not recognized as a medical ailment. Lilly proposes to restrict the hormone to boys predicted to be shorter than 5-feet, 3-inches as adults, and girls shorter than 4-feet, 11 inches. Clinical trials suggest those children can increase their height by a few inches, (http://reuters.com/financeNewsArticle.jhtml?type=governmentFilingsNews&storyID= 2908568) enough to bring them within a standard deviation of the population mean.
Humatrope isn't without its drawbacks: Treatment requires six injections a week for two to five years, can cost $10,000 to $20,000 per child annually (health insurance plans are not expected to pay for treatment), and can have unpleasant side effects. (http://www.humatrope.com/healthcareprofs/adult/safety.jsp) Those drawbacks are likely to make a decision to use Humatrope difficult for parents, as they decide whether avoiding the stigma of being short is worth it.
Others questions whether the "medicalization of shortness" (http://www.newsday.com/news/health/ny-hstall113327977jun11,0,5335925.story?coll=ny-health-headlines) in healthy children is wise at all--especially given the difficulty in accurately predicting (http://www.fdaadvisorycommittee.com/FDC/AdvisoryCommittee/Committees/Endocrinologic+and+Metabolic+Drugs/061003_Humatrope/061003_humatropeP.htm) how tall children will grow without treatment.
So what say you? IS peer pressure of being "vertically challenged" (we must since the PC phrase exists for it) worth all of this? Or are we all going way too far with this?
The growth hormone Humatrope (http://www.humatrope.com/index.jsp) makes children grow taller. For years, it's been used to treat children with growth hormone deficiency and Turner syndrome. But now its manufacturer, Eli Lily & Co., has taken an important step towards selling Humatrope to a much larger population. A panel advising the Food and Drug Administration recommended expanding the use of Humatrope to make healthy but short children grow a few extra inches. (http://online.wsj.com/article_email/0,,SB10552760005584800,00.html)
If the FDA accepts the panel's recommendation, Eli Lily will be allowed to market the drug to pediatric endocrinologists to "treat" a condition that is not recognized as a medical ailment. Lilly proposes to restrict the hormone to boys predicted to be shorter than 5-feet, 3-inches as adults, and girls shorter than 4-feet, 11 inches. Clinical trials suggest those children can increase their height by a few inches, (http://reuters.com/financeNewsArticle.jhtml?type=governmentFilingsNews&storyID= 2908568) enough to bring them within a standard deviation of the population mean.
Humatrope isn't without its drawbacks: Treatment requires six injections a week for two to five years, can cost $10,000 to $20,000 per child annually (health insurance plans are not expected to pay for treatment), and can have unpleasant side effects. (http://www.humatrope.com/healthcareprofs/adult/safety.jsp) Those drawbacks are likely to make a decision to use Humatrope difficult for parents, as they decide whether avoiding the stigma of being short is worth it.
Others questions whether the "medicalization of shortness" (http://www.newsday.com/news/health/ny-hstall113327977jun11,0,5335925.story?coll=ny-health-headlines) in healthy children is wise at all--especially given the difficulty in accurately predicting (http://www.fdaadvisorycommittee.com/FDC/AdvisoryCommittee/Committees/Endocrinologic+and+Metabolic+Drugs/061003_Humatrope/061003_humatropeP.htm) how tall children will grow without treatment.
So what say you? IS peer pressure of being "vertically challenged" (we must since the PC phrase exists for it) worth all of this? Or are we all going way too far with this?